T1	Participants 410 540	90 Brazilian women, diagnosed to CIN2 and high-risk human papillomavirus infection, were randomized into two groups of equal size:
T2	Participants 796 827	45 women in the follow-up group
T3	Participants 1067 1076	patients.
